| Literature DB >> 20543579 |
Meng Hua Tao1, Jo L Freudenheim.
Abstract
Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant epigenetic change is aberrant DNA methylation. In this review, we review evidence on the role of aberrant DNA methylation, examining changes in relation to endometrial carcinogenesis, and report on recent advances in the understanding of the contribution of aberrant DNA methylation to endometrial cancer with the emphasis on the role of dietary/ lifestyle and environmental factors, as well as opportunities and challenges of DNA methylation in endometrial cancer management and prevention.Entities:
Mesh:
Year: 2010 PMID: 20543579 PMCID: PMC2954259 DOI: 10.4161/epi.5.6.12431
Source DB: PubMed Journal: Epigenetics ISSN: 1559-2294 Impact factor: 4.528